miR-146a Regulates Neuroinflammation and Immune Cell Function in Neurodegenerative Diseases

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Neurodegenerative diseases (NDDs) involve progressive cognitive, behavioral, and memory decline.
• MicroRNAs (miRNAs) are small noncoding RNAs vital for neuronal function and survival, regulating gene expression.
• miR-146a, dependent on nuclear factor κB (NF-κB), acts as an anti-inflammatory miRNA in the central nervous system via the Toll-like receptor (TLR) pathway.

Purpose of the Study:

• To review the critical role of miR-146a in the pathogenesis and progression of neurodegenerative diseases.
• To highlight the association between miR-146a genetic variations (polymorphisms) and NDD risk.
• To discuss the therapeutic potential of targeting miR-146a for NDD treatment.

Main Methods:

• Literature review summarizing existing research on miR-146a in neurodegenerative diseases.
• Analysis of the relationship between miR-146a expression levels, polymorphisms, and NDD development.
• Examination of miR-146a's target genes involved in neuroinflammatory pathways.

Main Results:

• Alterations in miR-146a expression levels are a significant factor in the pathogenesis of various NDDs.
• miR-146a polymorphisms are associated with an increased risk of developing neurodegenerative diseases.
• miR-146a regulates key genes in inflammatory signaling pathways, directly impacting neuroinflammation in NDDs.

Conclusions:

• miR-146a plays a central role in the neuroinflammatory processes underlying neurodegenerative diseases.
• miR-146a demonstrates promise as a potential biomarker for early detection and diagnosis of NDDs.
• Targeting miR-146a offers a potential therapeutic strategy for managing neuroinflammation and treating NDDs.